Product Profiles

Platform for both the anterior and posterior eye segments

This instrument enables surgeons to perform most modern operating techniques, whether it be coaxial micro-incision surgery or with the easyPhaco® Technology in the anterior segment or minimal invasive pars plana vitrectomy in the posterior segment. The device also features a high performance peristaltic pump that ensures a high level of chamber stability, efficient removal of the vitreous body and precise work near the retina. Additionally, this instrument features a Goodlight light source that, when used with the company's light instruments, reportedly provides the user with optimal illumination.

For more detailed information on this instrument visit http://www.oertli-instruments.com/

Reusable rings for Epi-K

MORIA, a manufacturer specializing in automated microkeratomes for refractive surgery, has created a range of reuable metallic rings for Epi-K epikeratome in 0, +1 and +2 sizes.

The rings allow refractive surgeons to make smaller epithelial resections that are still adequate for the 6.0 mm zone treatments. This allows for quicker healing, earlier removal of the bandage contact lens and a vastly improved experience for the patient. Studies show that 97.5% of patients had a fully healed epithelium after the product was used on them. For more detailed information on these rings and other Moria products visit http://www.moria-surgical.com/

Wide range of MICS IOLs

There are many advantages associated with MICS including no surgery induced astigmatism, rapid visual recovery and low risk of endothelial cell loss. The company states that its IOLs have been proven to provide good outcomes.

To learn more about the IOLs available from Carl Zeiss Meditec visit http://www.meditec.zeiss.com/iol

Ultra-widefield retinal imaging device

Optos has launched an ultra-widefield retinal imaging device specifically designed for general ophthalmologists and vitreo-retinal specialists. The 200Tx supports the diagnosis, analysis, documentation and monitoring of ocular pathology in the periphery of the retina.

The company claims that this instrument is the first to provide visualisation of ultra-widefield autofluorescence changes to retinal pigment epithelium (RPE). Additionally, the device offers multiple wavelength imaging including options for colour, red-free, fluorescein angiography and autofluorescence to provide the user with different pathologies. Another feature is the simultaneous pole to periphery views of more than 80% or 200 degrees of the retina in a single capture.

For more information visit the company's website at http://www.optos.com/